PLUS1
Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| CHF Solutions Inc | CHFS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.052 | -6.58% | 0.7382 | 0.80 | 0.72 | 0.79 | 0.7902 | 19:59:39 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.73 | 0.80 | 0.07 | 8.75% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 300 | 103,831 | $ 0.7620418 | $ 79,124 | 1,429,143 | 0.40 - 14.14 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:59:39 | 70 | $ 0.7301 | USD |
CHF Solutions Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 3.12M | 4.22M | $ -17.03M | -44.18 | - | 1.91M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 1.00 | - |
CHF Solutions News
| Date | Time | Source | News Article |
|---|---|---|---|
| 12/06/2019 | 17:22 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 12/06/2019 | 09:10 | Edgar (US Regulatory) | Securities Registration Statement (s-1) |
| 12/03/2019 | 08:00 | GlobeNewswire Inc. | CHF Solutions Announces Launch of Ultrafiltration Therapy.. |
| 11/27/2019 | 16:31 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) |
| 11/21/2019 | 17:19 | Edgar (US Regulatory) | Small Company Offering and Sale of Securities Without.. |
| 11/15/2019 | 17:30 | GlobeNewswire Inc. | CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ.. |
| 11/14/2019 | 16:18 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CHFS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.94 | 1.03 | 0.72 | 0.8047047 | 242,004 | -0.2018 | -21.47% |
| 1 Month | 0.725 | 1.03 | 0.60 | 0.7865616 | 210,831 | 0.0132 | 1.82% |
| 3 Months | 2.27 | 2.55 | 0.60 | 1.21 | 822,371 | -1.53 | -67.48% |
| 6 Months | 2.98 | 3.75 | 0.60 | 1.39 | 429,296 | -2.24 | -75.23% |
| 1 Year | 0.79 | 14.14 | 0.40 | 2.11 | 294,213 | -0.0518 | -6.56% |
| 3 Years | 8.80 | 220.60 | 0.40 | 14.34 | 551,363 | -8.06 | -91.61% |
| 5 Years | 85.80 | 220.60 | 0.40 | 17.97 | 424,879 | -85.06 | -99.14% |
CHF Solutions Description
| CHF Solutions Inc is an early-stage medical device company based in the US. It focuses on commercializing the Aquadex FlexFlow System. The Aquadex FlexFlow System is used for temporary and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. It is designed to remove excess fluid ( primarily excess salt and water) from patients suffering from fluid overload who have failed diuretic therapy. The company operates through a single segment being Cardiac and coronary disease products. |
